It is known that implantable cardioverter defibrillators ICDs provide a significant mortality benefit for appropriately selected patients with advanced heart failure. The mortality benefit has been shown in patients with a pulsatile left ventricular assist device LVAD however it remains unclear whether patients with a continuous flow LVAD CF LVAD derive the same benefit. Thus the investigators performed a study to determine if the presence of an ICD provided a mortality benefit during CF LVAD support as a bridge to transplantation. The results published in the Journal of Heart and Lung Transplantation showed no difference in survival during device support between patients with and without an ICD. Thus it was concluded that ICD does not provide mortality benefit in patients bridged to transplantation with a CF LVAD.